SCHEMBL17825684

SCHEMBL17825684

Cc1ncn(-c2ccccc2C(N)=O)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
MAPT P10636 4/20 0.41
LMNA P02545 2/20 0.41
PARP1 P09874 6/20 0.41
PLK1 P53350 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
PARP3 Q9Y6F1 1/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PKM P14618 2/20 0.36
METAP2 P50579 1/20 0.36
RPS6KB1 P23443 1/20 0.36
MYC P01106 1/20 0.36
NR4A1 P22736 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201996 0.74 FLT3 (0.44) MAPTLMNAALDH1A1HPGDTSHR
SCHEMBL3346133 0.73 SIRT3 (0.38) MAPTLMNAPARP1PARP2PARP3
SCHEMBL299870 0.72 HCRTR1 (0.48) NPC1MAPTLMNAPARP1KDM4E
SCHEMBL3328193 0.71 NPC1 (0.57) NPC1MAPTKDM4EALDH1A1RAB9A
SCHEMBL30444401 0.71 NPC1 (0.57) NPC1MAPTKDM4EALDH1A1RAB9A
SCHEMBL1955751 0.71 ALDH1A1 (0.41) MAPTLMNAKDM4EALDH1A1HPGD
SCHEMBL14064641 0.71 NCF1 (0.39) MAPTLMNASMN1; SMN2
SCHEMBL16277896 0.71 CSNK2A1 (0.45) MAPTLMNAKDM4EALDH1A1PKM
Hydrochloric Acid SCHEMBL4832614 0.70 PDE9A (0.38) MAPTLMNASMN1; SMN2
SCHEMBL15157469 0.69 NPC1 (0.51) NPC1MAPTLMNAPARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3258929-A1 FACTOR IXa INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-12-27 EP claimed
EP-3229801-A1 FACTOR IXA INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-10-18 EP claimed
WO-2016133793-A1 FACTOR IXa INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-08-25 WO claimed
WO-2016094260-A1 FACTOR IXA INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-06-16 WO claimed